BIOCATALYSTS MINED FROM CYTOCHROME P450 LIBRARIES: AN INNOVATIVE TOOL FOR ACCELERATING DRUG DEVELOPMENT. The cytochrome P450s (P450s) are a family of enzymes that are perhaps the most versatile biological catalysts known. DNA shuffling is an emerging technique that takes the genes encoding families of enzymes and creates libraries of catalysts with both improved and novel properties. We will obtain proof of concept that shuffled P450 libraries can be screened and optimized for use as biocatalys ....BIOCATALYSTS MINED FROM CYTOCHROME P450 LIBRARIES: AN INNOVATIVE TOOL FOR ACCELERATING DRUG DEVELOPMENT. The cytochrome P450s (P450s) are a family of enzymes that are perhaps the most versatile biological catalysts known. DNA shuffling is an emerging technique that takes the genes encoding families of enzymes and creates libraries of catalysts with both improved and novel properties. We will obtain proof of concept that shuffled P450 libraries can be screened and optimized for use as biocatalysts in drug development. The methodologies developed here will overcome two critical bottlenecks in current drug development: the optimisation and metabolic profiling of new drug candidates. This will yield important benefits in accelerating the optimisation and safety testing of drugs under development.Read moreRead less
Targeting virulence of Pseudomonas aeruginosa by inhibiting oxidative protein folding. Our research will lead to the development of compounds with a novel anti-virulence/antibacterial mode of action for further drug development.
Diversity of Salinispora actinobacteria producing pharmaceutically relevant natural products from Australian marine sponges. By investigating the distribution of marine microbial resources relevant to drug discovery, we will directly contribute to ARC's Research Priority I - An Environmentally Sustainable Australia Priority Goal and the Priority Goal 'Sustainable use of Australia's biodiversity'. We will determine sources of marine bacteria and their genes useful for discovery of new natural pro ....Diversity of Salinispora actinobacteria producing pharmaceutically relevant natural products from Australian marine sponges. By investigating the distribution of marine microbial resources relevant to drug discovery, we will directly contribute to ARC's Research Priority I - An Environmentally Sustainable Australia Priority Goal and the Priority Goal 'Sustainable use of Australia's biodiversity'. We will determine sources of marine bacteria and their genes useful for discovery of new natural products for treatment of human diseases. We will do this by understanding where new strains of Salinispora bacteria may be isolated and how they are distributed in association with Australian marine sponge fauna, and by determining the distribution and chemical and genetic diversity of novel marine Salinispora bacteria.Read moreRead less